Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 26,355Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Incyte Biosciences Distribution B.V.

02 1Incyte Biosciences Distribution Bv

03 1Incyte Biosciences International S?rl

04 9Novartis Europharm Limited

05 5Novartis Pharma Schweiz Ag

06 3Orifarm AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib

Brand Name : Opzelura g

Dosage Form : Cream

Dosage Strength : 15mg

Packaging :

Approval Date : 30/01/2025

Application Number : 69443

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 15mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 20mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Oral Solution

Dosage Strength : 5mg/ml

Packaging :

Approval Date : 27/03/2025

Application Number : 69722

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 03/10/2014

Application Number : 20140311000017

Regulatory Info : Approved

Registration Country : Sweden

blank

08

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 15 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 20 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 5 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank